Therapeutics: Gap junction protein α 1, 43kDa (GJA1; CX43; connexin-43); protocadherin 7 (PCDH7)

Cancer

INDICATION: Breast cancer; non-small cell lung cancer (NSCLC); cancer

Patient sample and mouse studies suggest inhibiting GJA1 or PCDH7

Read the full 187 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE